ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

NA-Semax

NA-Semax

Also known as: N-Acetyl Semax, Acetylated Semax, NA-Semax Amidate

Overview

Key Facts

Primary Goal: Research and therapeutic applications of NA-Semax

Same melanocortin receptor (MC3/MC4) and BDNF-promoting mechanisms as Semax. N-acetyl group provides resistance to aminopeptidase degradation at the N-terminus.

Dosing Information

Half-Life

~20-60 minutes (extended over parent Semax)

Typical Dose

100–600 mcg

Frequency

1-2 times daily

Cycle Length

10-30 days

Administration Routes:
subcutaneous

Benefits

  • Enhanced BDNF upregulation compared to standard Semax
  • Longer-lasting nootropic and neuroprotective effects
  • Improved focus, mental clarity, and verbal fluency
  • Greater metabolic stability and CNS penetration
  • Potential for more sustained neuroprotection in ischemic conditions

Side Effects

Mild nasal irritation with intranasal usemild
Headache, particularly at higher dosesmild
Anecdotal reports of irritability or overstimulationmild
Hair shedding reported at high doses (similar to parent compound)mild

Mechanism of Action

1

Same melanocortin receptor (MC3/MC4) and BDNF-promoting mechanisms as Semax

2

N-acetyl group provides resistance to aminopeptidase degradation at the N-terminus

3

Enhanced blood-brain barrier penetration increases central neurotrophic effects

4

Modulates dopaminergic and serotonergic neurotransmission with improved pharmacokinetic profile

Contraindications

Do not use this peptide if any of the following apply:

  • Active seizure disorders
  • Pregnancy or breastfeeding
  • Known hypersensitivity to ACTH-derived peptides

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Note: Protect from light. Do not freeze reconstituted solution.

Research Summary

Preclinical

NA-Semax builds on the extensive Russian clinical research behind standard Semax by incorporating an N-acetyl modification for improved pharmacokinetics. Preclinical studies suggest that the acetylated form may produce greater BDNF elevation per dose compared to unmodified Semax. While it lacks the independent clinical trial data of its parent compound, the pharmacological rationale for the modification is well-established, and it has become one of the most popular nootropic peptides in research communities seeking enhanced potency over standard Semax.

Frequently Asked Questions

Common questions about NA-Semax

UK-Specific Information

Exclusive data points and guidance for UK residents using NA-Semax

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok